Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2.

Xiang Q, Tang H, Yu J, Yin J, Yang X, Lei X.

Pharmazie. 2013 Apr;68(4):274-81.

PMID:
23700794
2.

Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.

Lei X, Huang Z, Zhong M, Zhu B, Tang S, Liao D.

Acta Biochim Biophys Sin (Shanghai). 2007 May;39(5):344-50.

3.

Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL.

Zhan M, Qu Q, Wang G, Zhou H.

Pharmazie. 2013 Dec;68(12):955-61.

PMID:
24400442
4.

MiR-122 increases sensitivity of drug-resistant BEL-7402/5-FU cells to 5-fluorouracil via down-regulation of bcl-2 family proteins.

Yin J, Tang HF, Xiang Q, Yu J, Yang XY, Hu N, Lei XY.

Pharmazie. 2011 Dec;66(12):975-81.

PMID:
22312705
5.

Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.

Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX, Yao XY, Peng Y, Cao J.

Tumour Biol. 2016 Feb;37(2):2387-94. doi: 10.1007/s13277-015-4017-7. Epub 2015 Sep 16.

PMID:
26376998
6.

[The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].

Wu Y, Guo L, Liu J, Liu R, Liu M, Chen J.

Zhongguo Fei Ai Za Zhi. 2014 Jan;17(1):1-7. doi: 10.3779/j.issn.1009-3419.2014.01.01. Chinese.

7.

Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.

Yu G, Zhong N, Chen G, Huang B, Wu S.

Tumour Biol. 2014 Oct;35(10):10341-9. doi: 10.1007/s13277-014-2284-3. Epub 2014 Jul 21.

PMID:
25038915
8.

Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide.

Huang Z, Lei X, Zhong M, Zhu B, Tang S, Liao D.

Acta Biochim Biophys Sin (Shanghai). 2007 Nov;39(11):835-43.

9.

Let-7 g microRNA sensitizes fluorouracil-resistant human hepatoma cells.

Tang H, Zhang P, Xiang Q, Yin J, Yu J, Yang X, Lei X.

Pharmazie. 2014 Apr;69(4):287-92.

PMID:
24791593
10.

[Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].

He J, Song X, Yu L, Li J, Qiao Z, Jiu R, Yu B, Liu X.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 May;31(5):625-9. Chinese.

PMID:
25940289
11.

C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.

Xie C, Pan Y, Hao F, Gao Y, Liu Z, Zhang X, Xie L, Jiang G, Li Q, Wang E.

APMIS. 2014 Dec;122(12):1251-8. doi: 10.1111/apm.12296. Epub 2014 Aug 6.

PMID:
25131138
12.

[Curcumin promoted the apoptosis of cisplain-resistant human lung carcinoma cells A549/DDP through down-regulating miR-186*].

Tang N, Zhang J, Du Y.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):301-6. doi: 10.3779/j.issn.1009-3419.2010.04.06. Chinese.

13.

[MiR-192 confers cisplatin resistance by targeting Bim in lung cancer].

Zhang F, Li Y, Wu H, Qi K, You J, Li X, Zu L, Pan Z, Wang Y, Li Y, Li Y, Wang M, Shen W, Zhou Q.

Zhongguo Fei Ai Za Zhi. 2014 May;17(5):384-90. doi: 10.3779/j.issn.1009-3419.2014.05.04. Chinese.

14.
15.

[The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].

Wang JQ, Du ZW, Gao XF, Wu M, Zhang YC, Pan Y, Wang Q, Zhang GZ.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Mar;36(3):191-7. Chinese.

PMID:
23856142
16.

[The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].

Ren L, Huang C, Liu YH, Yu Y, Lin L, Wen LJ.

Zhonghua Yi Xue Za Zhi. 2016 May 17;96(18):1454-8. doi: 10.3760/cma.j.issn.0376-2491.2016.18.014. Chinese.

PMID:
27266356
17.

MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.

Ma Y, Li X, Cheng S, Wei W, Li Y.

Mol Med Rep. 2015 Jan;11(1):625-32. doi: 10.3892/mmr.2014.2688. Epub 2014 Oct 17.

PMID:
25339370
18.

β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.

Yao CC, Tu YR, Jiang J, Ye SF, Du HX, Zhang Y.

Oncol Rep. 2014 May;31(5):2131-8. doi: 10.3892/or.2014.3083. Epub 2014 Mar 12.

PMID:
24627125
19.

Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).

Wang Q, Zhong M, Liu W, Li J, Huang J, Zheng L.

Exp Lung Res. 2011 Sep;37(7):427-34. doi: 10.3109/01902148.2011.584263. Epub 2011 Jul 25.

PMID:
21787234
20.

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549).

Bian HB, Pan X, Yang JS, Wang ZX, De W.

J Exp Clin Cancer Res. 2011 Feb 17;30:20. doi: 10.1186/1756-9966-30-20.

Supplemental Content

Support Center